Clinical Trials Logo

Clinical Trial Summary

Objectives: To evaluate the safety of outpatient treatment of patients with very low-risk pulmonary embolism (PE), and the satisfaction and quality of life of this management. Methods: An experimental study of routine clinical practice will be carried out in which 300 consecutive hemodynamically stable patients with acute symptomatic PE will be included, who meet all the inclusion criteria and none of the exclusion criteria. All patients included in the study will be treated on an outpatient basis, that is, they will be discharged within the first 24 hours of the diagnosis of PE in the Emergency Department. The Computerized Registry of Thromboembolic Disease RIETE (Registro Informatizado de Enfermedad TromboEmbólica) will be used to collect the data in electronic case report form (CRF) and ensure the quality of the data. Setting: Emergency, Pneumology and Internal Medicine Services of 10 Spanish hospitals. Analysis: An intention-to-treat (ITT) analysis will be performed on all patients who sign the informed consent and are included in the study (regardless of whether or not they receive the assigned strategy). Additionally, an analysis of all patients who are treated on an outpatient basis without deviations or violations of the protocol will be performed. The primary outcome considered will be the composite of recurrent PE, major bleeding, or death from any cause during the first 30 days after enrollment in the study. Patient satisfaction and quality of life will be considered as secondary outcomes.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05852119
Study type Interventional
Source Clinica Universidad de Navarra, Universidad de Navarra
Contact PEDRO Ruiz-Artacho, PhD, MD
Phone 636781570
Email pruiza@unav.es
Status Recruiting
Phase N/A
Start date April 10, 2023
Completion date February 28, 2026

See also
  Status Clinical Trial Phase
Completed NCT00519506 - A Phase II Study to Evaluate the Efficacy of ThromboView® in the Detection of Pulmonary Emboli Phase 2
Not yet recruiting NCT04110275 - Injection of Recombinant Human Tissue-type Plasminogen Activator Derivative for Acute Pulmonary Embolism(rPA) Phase 2
Completed NCT05318092 - Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary Embolism N/A
Not yet recruiting NCT06189313 - CLEANer Aspiration for Pulmonary Embolism N/A
Not yet recruiting NCT05792397 - TwiFlow Thrombectomy Catheter sYstem for Acute Pulmonary Embolism (Twi-TYPE Study) N/A
Completed NCT01604538 - Italian Pulmonary Embolism Registry - IPER N/A
Completed NCT03631810 - Contemporary Clinical Management Of Acute Pulmonary Embolism
Recruiting NCT03504007 - Registry of Patients Prescribed Anticoagulation
Completed NCT01513759 - Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy Phase 3
Completed NCT03108833 - A Trial in Recombinant Human Prourokinase to Treat Acute Pulmonary Embolism Phase 2
Completed NCT04037423 - European Database on Catheter-directed Treatment of Pulmonary Embolism.
Not yet recruiting NCT05469724 - Clinical Pulmonary Embolism
Completed NCT01014156 - Epoprostenol in Pulmonary Embolism Phase 4
Recruiting NCT06038630 - 129Xe MRI Cardiopulmonary Phase 2
Recruiting NCT06192199 - The Diagnostic Value of APTT/Fibrinogen Ratio in Pulmonary Embolism
Recruiting NCT04757129 - Changes of Cardiopulmonary Function After Thrombolysis in Patients With Pulmonary Embolism
Completed NCT03966079 - Thrombolysis Endovascular Treatment of Pulmonary Embolism Phase 3
Recruiting NCT03916302 - Pulmonary Embolism WArsaw REgistry
Recruiting NCT06062329 - SYMPHONY-PE Study for Treatment of Pulmonary Embolism N/A
Not yet recruiting NCT04480892 - Fibrinolytic Deficit in Patients With Acute PE